Cargando…
Analysis of coumarin and angelica lactones in smokeless tobacco products
Differences in health risks between different styles of smokeless tobacco products (STPs) have prompted interest in their relative levels of toxic chemicals. We report here the development of methods for the analysis of STPs for coumarin and for α-angelica lactone (α-AL), both of which have been inc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768314/ https://www.ncbi.nlm.nih.gov/pubmed/30569337 http://dx.doi.org/10.1186/s13065-018-0506-2 |
_version_ | 1783455082642145280 |
---|---|
author | McAdam, Kevin Enos, Trevor Goss, Carol Kimpton, Harriet Faizi, Arif Edwards, Steve Wright, Christopher Porter, Andrew Rodu, Brad |
author_facet | McAdam, Kevin Enos, Trevor Goss, Carol Kimpton, Harriet Faizi, Arif Edwards, Steve Wright, Christopher Porter, Andrew Rodu, Brad |
author_sort | McAdam, Kevin |
collection | PubMed |
description | Differences in health risks between different styles of smokeless tobacco products (STPs) have prompted interest in their relative levels of toxic chemicals. We report here the development of methods for the analysis of STPs for coumarin and for α-angelica lactone (α-AL), both of which have been included in various published lists of tobacco toxicants. We have also determined the concentrations of these lactones in commercial STPs from the US and Sweden, representing 80–90% of the 2010 market share for all the major STP categories in these two countries: 65 products (plus two reference products) for coumarin and 66 commercial products for α-AL. For coumarin, methanol extracts of the STPs were analysed by HPLC/MS/MS. The lower limit of quantification (LOQ) and limit of detection (LOD) were, respectively, 100 and 30 ng coumarin/g of STP on a wet weight basis (WWB). Alpha-AL was determined via direct headspace GC/MS. The LOQ and LOD were 65 and 30 ng/g WWB respectively. Coumarin was detected In 3/33 Swedish snus, 5/13 US chewing tobaccos, 16/16 moist snuffs and 5/6 dry snuffs. Concentrations in those samples with quantifiable coumarin contents ranged from 186 to 1656 ng/g WWB. Concentrations of coumarin measured in this study were consistent with levels naturally found in tobacco. None of the STPs analysed would significantly contribute to coumarin exposure in consumers compared with dietary sources, and estimated exposure levels were 1000× lower than the European Food Safety Authority Tolerable Daily Intake. Hence the relevance of coumarin to the toxicity of STPs and its inclusion in the FDA’s list of harmful and potentially harmful compounds list is questionable. Measurements of α-AL in these STPs found that the majority did not have quantifiable contents, however, for three STPs concentrations of α-AL were above the LOQ (116–140 ng/g WWB) and for four other STPs concentrations of α-AL could be estimated between the LOD and LOQ. Beta-angelica lactone was tentatively identified in three of the STPs but the levels could not be reliably quantified. The levels of α-AL in tobacco products are reported here for the first time, but the relevance of α-AL to the toxicity of STPs is also highly questionable given that it has GRAS status as a permitted food additive. |
format | Online Article Text |
id | pubmed-6768314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-67683142019-10-03 Analysis of coumarin and angelica lactones in smokeless tobacco products McAdam, Kevin Enos, Trevor Goss, Carol Kimpton, Harriet Faizi, Arif Edwards, Steve Wright, Christopher Porter, Andrew Rodu, Brad Chem Cent J Research Article Differences in health risks between different styles of smokeless tobacco products (STPs) have prompted interest in their relative levels of toxic chemicals. We report here the development of methods for the analysis of STPs for coumarin and for α-angelica lactone (α-AL), both of which have been included in various published lists of tobacco toxicants. We have also determined the concentrations of these lactones in commercial STPs from the US and Sweden, representing 80–90% of the 2010 market share for all the major STP categories in these two countries: 65 products (plus two reference products) for coumarin and 66 commercial products for α-AL. For coumarin, methanol extracts of the STPs were analysed by HPLC/MS/MS. The lower limit of quantification (LOQ) and limit of detection (LOD) were, respectively, 100 and 30 ng coumarin/g of STP on a wet weight basis (WWB). Alpha-AL was determined via direct headspace GC/MS. The LOQ and LOD were 65 and 30 ng/g WWB respectively. Coumarin was detected In 3/33 Swedish snus, 5/13 US chewing tobaccos, 16/16 moist snuffs and 5/6 dry snuffs. Concentrations in those samples with quantifiable coumarin contents ranged from 186 to 1656 ng/g WWB. Concentrations of coumarin measured in this study were consistent with levels naturally found in tobacco. None of the STPs analysed would significantly contribute to coumarin exposure in consumers compared with dietary sources, and estimated exposure levels were 1000× lower than the European Food Safety Authority Tolerable Daily Intake. Hence the relevance of coumarin to the toxicity of STPs and its inclusion in the FDA’s list of harmful and potentially harmful compounds list is questionable. Measurements of α-AL in these STPs found that the majority did not have quantifiable contents, however, for three STPs concentrations of α-AL were above the LOQ (116–140 ng/g WWB) and for four other STPs concentrations of α-AL could be estimated between the LOD and LOQ. Beta-angelica lactone was tentatively identified in three of the STPs but the levels could not be reliably quantified. The levels of α-AL in tobacco products are reported here for the first time, but the relevance of α-AL to the toxicity of STPs is also highly questionable given that it has GRAS status as a permitted food additive. Springer International Publishing 2018-12-20 /pmc/articles/PMC6768314/ /pubmed/30569337 http://dx.doi.org/10.1186/s13065-018-0506-2 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article McAdam, Kevin Enos, Trevor Goss, Carol Kimpton, Harriet Faizi, Arif Edwards, Steve Wright, Christopher Porter, Andrew Rodu, Brad Analysis of coumarin and angelica lactones in smokeless tobacco products |
title | Analysis of coumarin and angelica lactones in smokeless tobacco products |
title_full | Analysis of coumarin and angelica lactones in smokeless tobacco products |
title_fullStr | Analysis of coumarin and angelica lactones in smokeless tobacco products |
title_full_unstemmed | Analysis of coumarin and angelica lactones in smokeless tobacco products |
title_short | Analysis of coumarin and angelica lactones in smokeless tobacco products |
title_sort | analysis of coumarin and angelica lactones in smokeless tobacco products |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768314/ https://www.ncbi.nlm.nih.gov/pubmed/30569337 http://dx.doi.org/10.1186/s13065-018-0506-2 |
work_keys_str_mv | AT mcadamkevin analysisofcoumarinandangelicalactonesinsmokelesstobaccoproducts AT enostrevor analysisofcoumarinandangelicalactonesinsmokelesstobaccoproducts AT gosscarol analysisofcoumarinandangelicalactonesinsmokelesstobaccoproducts AT kimptonharriet analysisofcoumarinandangelicalactonesinsmokelesstobaccoproducts AT faiziarif analysisofcoumarinandangelicalactonesinsmokelesstobaccoproducts AT edwardssteve analysisofcoumarinandangelicalactonesinsmokelesstobaccoproducts AT wrightchristopher analysisofcoumarinandangelicalactonesinsmokelesstobaccoproducts AT porterandrew analysisofcoumarinandangelicalactonesinsmokelesstobaccoproducts AT rodubrad analysisofcoumarinandangelicalactonesinsmokelesstobaccoproducts |